Eric P. Kusnadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eric P. Kusnadi has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Richard B. Pearson
Peter MacCallum Cancer Centre
19 shared publications - Katherine M. Hannan
Australian Cancer Research Foundation Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia
15 shared publications - Ross D. Hannan
John Curtin School of Medical Research, Australian National University, Australian Capital Territory, Canberra, Australia
15 shared publications - Carleen Cullinane
Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
13 shared publications - Grant A. McArthur
Cancer Research Division and Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
12 shared publications - Elaine Sanij
St Vincent’s Institute of Medical Research, Fitzroy, Australia
11 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in Research Square
Translational reprogramming drives chromosomal instability during tumorigenesis
Chromosomal instability (CIN) is a defining hallmark of cancer that drives genomic evolution, yet the molecular mechanisms triggering CIN during early tumorigenesis remain poorly defined. Here, we identify translation as a critical gatekeeper of chromosomal integrity during tumor initiation. Using models of tumorigenesis driven by SMAD4 loss, we integrate CRISPR-Cas9 screening, polysome profiling, and in vivo approaches to demonstrate that this disruption triggers a selective translational reprogramming that impairs mitotic fidelity. Specifically, SMAD4 deficiency alters the global translational landscape and suppresses translation of key mitotic regulator CDK11B. Re-expression of the mitosis-specific isoform CDK11B-p58 rescues these defects and suppresses tumorigenesis, establishing it as a primary effector in this pathway. Importantly, patient tumor analyses reveal a robust correlation between SMAD4 and CIN markers across multiple cancer types. Collectively, our findings uncover a translationally mediated axis of CIN, offering a new mechanism for CIN-driven tumor initiation.
- 29 September 2026
- Published by Springer Nature in Research Square
Open AccessTranslational reprogramming drives chromosomal instability during tumorigenesis
Chromosomal instability (CIN) is a defining hallmark of cancer that drives genomic evolution, yet the molecular mechanisms triggering CIN during early tumorigenesis remain poorly defined. Here, we identify translation as a critical gatekeeper of chromosomal integrity during tumor initiation. Using models of tumorigenesis driven by SMAD4 loss, we integrate CRISPR-Cas9 screening, polysome profiling, and in vivo approaches to demonstrate that this disruption triggers a selective translational reprogramming that impairs mitotic fidelity. Specifically, SMAD4 deficiency alters the global translational landscape and suppresses translation of key mitotic regulator CDK11B. Re-expression of the mitosis-specific isoform CDK11B-p58 rescues these defects and suppresses tumorigenesis, establishing it as a primary effector in this pathway. Importantly, patient tumor analyses reveal a robust correlation between SMAD4 and CIN markers across multiple cancer types. Collectively, our findings uncover a translationally mediated axis of CIN, offering a new mechanism for CIN-driven tumor initiation.
- Open Access
SMAD4 loss drives chromosomal instability during tumourigenesis via translational reprogramming
Chromosomal instability (CIN), arising from errors in chromosome segregation during cell division, is a hallmark of cancer. Whilst CIN can result from several mitotic defects, the mechanisms that initiate CIN to drive tumourigenesis remain incompletely understood. Here, we show that loss of SMAD4 reprograms translation to induce CIN, resulting in tumour formation. Multi-omics analysis of tumourigenesis models driven by loss of SMAD4 complemented by functional studies demonstrate that loss of SMAD4 in pre-neoplastic cells leads to dysfunctional mitosis and an altered global translation landscape. We show that CDK11B is translationally downregulated in SMAD4 -\- cells, and re-expression of the mitosis-specific isoform of this protein (CDK11B-p58) rescues the mitotic defects. Analysis of patient tumours reveals a strong correlation between markers of CIN and SMAD4 status, indicating the clinical relevance of this phenotype. Collectively, we reveal a previously unrecognised role for SMAD4 as a gatekeeper for CIN-mediated tumourigenesis via regulation of translation.
Open AccessSMAD4 loss drives chromosomal instability during tumourigenesis via translational reprogramming
Chromosomal instability (CIN), arising from errors in chromosome segregation during cell division, is a hallmark of cancer. Whilst CIN can result from several mitotic defects, the mechanisms that initiate CIN to drive tumourigenesis remain incompletely understood. Here, we show that loss of SMAD4 reprograms translation to induce CIN, resulting in tumour formation. Multi-omics analysis of tumourigenesis models driven by loss of SMAD4 complemented by functional studies demonstrate that loss of SMAD4 in pre-neoplastic cells leads to dysfunctional mitosis and an altered global translation landscape. We show that CDK11B is translationally downregulated in SMAD4 -\- cells, and re-expression of the mitosis-specific isoform of this protein (CDK11B-p58) rescues the mitotic defects. Analysis of patient tumours reveals a strong correlation between markers of CIN and SMAD4 status, indicating the clinical relevance of this phenotype. Collectively, we reveal a previously unrecognised role for SMAD4 as a gatekeeper for CIN-mediated tumourigenesis via regulation of translation.
- Open Access
Di-codon organization links tRNA modifications to cancer cell proteome composition
Hormone-signalling modulates levels of tRNA-modifying enzymes, including ELP3, in cancer cells. Here we show that ELP3 is required to sustain proliferation in prostate cancer cells. Intriguingly, although ELP3 modifies tRNA at the U34-position, the ELP3-sensitive proteome was poorly explained by frequencies of codons requiring U34-modified tRNA for decoding. Instead, we identified six codon pairs (herein denoted ELP3 down di-codons “E3dDCs”) that, in concert with local sequence context and 5’UTR features affecting translation initiation, explain ELP3-sensitive protein expression. Moreover, despite activation of the canonical integrated stress response upon ELP3 suppression, the associated expression program was paradoxically suppressed in a fashion correlating with higher E3dDC frequencies. E3dDCs were also enriched in mitotic regulators, and ELP3-suppression caused mitotic defects that limited proliferation. Therefore, ELP3 regulates proteome composition via E3dDCs that, depending on their local sequence context and translation initiation activity, determine protein expression and downstream cellular phenotypes upon reduced levels of U34-modified tRNA.
Open AccessDi-codon organization links tRNA modifications to cancer cell proteome composition
Hormone-signalling modulates levels of tRNA-modifying enzymes, including ELP3, in cancer cells. Here we show that ELP3 is required to sustain proliferation in prostate cancer cells. Intriguingly, although ELP3 modifies tRNA at the U34-position, the ELP3-sensitive proteome was poorly explained by frequencies of codons requiring U34-modified tRNA for decoding. Instead, we identified six codon pairs (herein denoted ELP3 down di-codons “E3dDCs”) that, in concert with local sequence context and 5’UTR features affecting translation initiation, explain ELP3-sensitive protein expression. Moreover, despite activation of the canonical integrated stress response upon ELP3 suppression, the associated expression program was paradoxically suppressed in a fashion correlating with higher E3dDC frequencies. E3dDCs were also enriched in mitotic regulators, and ELP3-suppression caused mitotic defects that limited proliferation. Therefore, ELP3 regulates proteome composition via E3dDCs that, depending on their local sequence context and translation initiation activity, determine protein expression and downstream cellular phenotypes upon reduced levels of U34-modified tRNA.